戻る Agenda
Clinical - Part II
Session Chair(s)
Cecil J. Nick, MS
FTOPRA, Vice President (Technical)
Parexel Consulting, United Kingdom
Jian Wang, MD, PHD
Division Manager, Clinical Review Division – Heamatology/Oncology
Health Canada, Canada
Clinical - Part II
Speaker(s)
Immunogenicity
Meena Subramanyam
Biogen Idec Inc., United States
Vice President, Development Translational Medicine
Interchangeability
Jaap Venema, PHD, PMP
Abbvie, United States
Therapeutic Area Lead Biotherapeutics, Global Medical Affairs
Jim Roach, MD, FACP
Pulmatrix, United States
Chief Medical Officer
Panel Discussion
All Session Speakers, United States